Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

November 18, 2013
169 Pages - SKU: VSG5182975
Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024


Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024

Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 - your guide to developments, opportunities and revenues

Where is the pharmaceutical anti-counterfeiting industry heading? Visiongain's brand new report lets you assess forecasted sales at overall world market, submarket, and national level to 2024.

Our 169 page study investigates technologies to tackle drug counterfeiters. Discover the most lucrative areas in that industry and market, seeing future outlooks.

Forecasts from 2014-2024 and other analyses show you commercial prospects

Besides revenue forecasting to 2024, our new study provides you with historical data, recent results, growth rates, and market shares. There you find original analyses, with business outlooks and developments (R&D). Discover qualitative analyses (SWOT and STEP), company profiles and commercial developments. You also receive two interviews, and 90 tables, figures and charts

You will find prospects for key technology submarkets

In addition to analyses of the overall world market, you see revenue forecasting of five technology submarkets to 2024:
  • RFID (radio frequency identification)
  • Security printing
  • Taggants
  • Holograms/OVD (optical variable devices)
  • Other pharma anti-counterfeiting technologies
Our investigation shows business research and analysis with individual revenue forecasts and discussions.

Prospects for leading countries are shown to 2024

Events and progress worldwide will influence the market, especially rising demand for supply chain security measures such as track-and-trace systems. Growth in this market will be fuelled by government mandates requiring serialisation solutions on products.

You discover individual revenue forecasts to 2024 for these geographical markets:
  • US
  • Japan
  • Germany, France, UK, Italy and Spain (EU5 Countries, as a group)
  • Brazil
  • Russia
  • India
  • China
  • RoW
The expected launch of new technologies from 2013 onwards will benefit regional and national markets. Greater uptake of existing technology worldwide will also stimulate the industry and market.

Companies and overall 2016 market revenue - what predicted growth?

Overall world revenue for pharmaceutical anti-counterfeiting technologies will reach $1.11bn in 2014. Rising concerns about counterfeit drugs worldwide will stimulate demand for drug security, authentication and verification solutions.

Our work profiles leading companies, assessing their technologies and products. You will see which technologies and organisations hold greatest potential.

In particular, we profile these leading organisations:
  • 3M
  • Authentix
  • Alien Technology
  • Colorcon
  • NanoGuardian
  • Thermo Scientific
  • Angstrom Technologies
  • AlpVision
  • Avery Dennison
  • Chesapeake
  • Covectra
  • Everest Holovisions
  • InkSure Technologies
  • Covectra
  • Intermec
  • TruTag Technologies
  • UPM Raflatac
  • Zebra Technologies
What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You will find discussions of many issues and developments, including R&D:
  • Parallel trade of medical products
  • Activities of trade bodies and governmental organisations
  • Security and efficiency of the pharma supply chain
  • Wholesalers and other pharma intermediaries
  • Actions taken by pharma companies
  • Trading channels and drug counterfeiters
  • Standards, regulations and policies
You see discussions of social, technological, economic and political matters, with emphasis on competing organisations and those shaping policy. Find out what the future holds.

Our investigation gives you multi-level business research and analysis with sales forecasts. You will see how the industry and market can perform from 2014 to 2024.

How the Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2014-2024 report helps you In summary, our report gives you the following knowledge:
  • Revenues forecasts to 2024 for the overall world pharmaceutical anti-counterfeiting technologies market and 5 submarkets - discover the industry's prospects
  • Revenues forecasts to 2024 for 5 pharmaceutical anti-counterfeiting technologies submarkets - discover promising areas for investments and revenues
  • Market forecasting to 2024 for the 8 key regions: US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), India, China, Brazil and Russia
  • Profiles of 17 prominent companies - assess product ranges, developments and strategies
  • Competition and opportunities - see what factors affect the pharmaceutical anti-counterfeiting market, learning what shapes its future, esp. prospects for sustaining and developing business
  • Opinions from our survey, seeing interviews with leading industry experts AlpVision and also a Leading Anti-counterfeiting Technologies Company Based in the US.
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed on business intelligence.

Please Note: Prior to initiating fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

The publisher is using a password system to access all reports. This password will be set up for single user and departmental licenses and will be emailed out to the client at the same time as the report. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.

Additional Information

The significant advantage of all types of RFID systems is the fact that authentication can be done
remotely as the technology does not require contact between reader and tag (Figure 3.3). Tags
can be read through a variety of substances such as snow, fog, ice, paint, dirt and other visually
and environmentally challenging conditions, where barcodes or other optically read technologies
would be useless. RFID tags can also be read in challenging circumstances at high speeds, in
most cases responding in less than 100 milliseconds. The read/write capability of an active RFID
system is also a significant advantage in interactive applications such as work-in-process or
maintenance tracking. Although it is a costlier technology (compared with barcodes), RFID has
become indispensable for a wide range of automated data collection and identification applications.

Companies Listed

Adhesives Research
Ahura Scientific
Alien Technologies
Altegrity Risk International
American Academy of Pediatrics (AAP)
American Express
Angstrom Technologies
Anti-Counterfeiting and Product Protection Programme (A-CAPPP)
Anti-Counterfeiting Group (ACG)
Applied DNA Sciences
ARmark Authentication Technologies LLC
Australian Therapeutic Goods Administration (TGA)
Avery Dennison
Canadian Anti-Counterfeiting Network (CACN)
Cellular Bioengineering Inc.
Center for Healthcare Supply Chain Research
Center for Medicine in the Public Interest (US)
CFC International
Digital China
Directorate General of Foreign Trade [India]
Drugs Standard Control Organisation
European Alliance for Access to Safe Medicines (EAASM)
European Commission
European Directorate for the Quality of Medicines and Healthcare (EDQM),
European Federation of Pharmaceutical Industries and Associations (EFPIA)
European Medicines Agency
Everest Holovisions
GlaxoSmithKline (GSK)
Healthcare Distribution Management Association (HDMA)
Heart UK
Hologram Industries
HOMAI (hologram manufactures association of India)
Honeywell International
Image Solutions
Impinj Inc
Ingenia Technology
InkSure Technologies
Intermec/ Interface Mechanisms
International Anti-counterfeiting Association (IAA)
International Anti-Counterfeiting Coalition (IACC)
International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
International Ink Company
International Medical Products Anti-Counterfeiting Taskforce (IMPACT)
International Policy Network
Japanese Pharmaceutical Manufacturers Association (JPMA)
Johnson & Johnson
Loughborough University
Massachusetts Institute of Technology (MIT)
Medicines and Healthcare products Regulatory Agency (MHRA)
Medicrime Convention Council
Menasha Corporation
MicroTag Temed Ltd
Microtrace Solutions
NanoInk Inc.
Nanotech Security Corp.
National Agency for Food and Drug Administration and Control (NAFDAC) [Nigeria]
National Association of Boards of Pharmacy (NABP)
National Health Surveillance Agency (ANVISA)
Neri Labels
OEP Technologie BV
One Equity Partners
OpSec Security
Organisation for Economic Co-operation and Development (OECD)
Pacific Holographics
Paralec Inc
Partner for Safe Medicines (PSM) India
Pera Innovations
Pharmaceutical Research and Manufacturers of America (PhRMA)
Quality Brands Protection Committee (QBPC) [China]
Reckitt Benckiser
Royal Pharmaceutical Society of Great Britain (RPSGB)
Savi Technology
Scientific Protein Laboratories (SPL)
South Dakota School of Mines and Technology
State Food and Drug Administration (SFDA) [China]
Sun Chemical
Symbol Technologies
Tagsys RFID
Teva Pharmaceuticals
Texas Instruments
The Caryle Group
The International Hologram Manufacturers Association
The Patients Association (UK)
The Pharmaceutical Security Institute (PSI)
ThermoFisher Scientific
TruTag Technologies
United Nations
University of South Dakota
UPM Kymmene
UPM Raflatac
UPM Rafsec z
US Center for Safe Internet Pharmacies (CSIP)
US Food and Drugs Agency (FDA)
US Pharmacopeial Convention (USP)
Vocollect Inc
World Customs Organization
World Health Organization (WHO)
World Intellectual Property Organization (WIPO)
Zebra Technologies

More Regulation & Policy reports by Visiongain

Pharma Leader Series - Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024 by Visiongain
Pharma Leader Series - Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024 Contract manufacturing for pharma – discover top companies’ revenue prospects How are pharma contract ...
Industry and Market Analysis - Pharmacovigilance and Related Developments 2014-2024 by Visiongain
About this Report Chinese Market Forecast, 2014-2024   At current levels, China is the national market with the greatest volume of safety data processed ...
Orphan Drugs for CNS Diseases: R&D and Market 2014-2024 by Visiongain
Orphan Drugs for CNS Diseases: R&D and Market 2014-2024 Uncommon nerve disorders - new study explains technological and commercial prospects What's the future of medicines ...
Brazilian Pharmaceutical Market 2014-2024 by Visiongain
Brazilian Pharmaceutical Market 2014-2024 Drug selling in Brazil - this new analysis shows you trends, opportunities, and revenues Do you want to assess ...
See all reports like this >>



    Electronic Access
Single User Fulfilled By Publisher
  USD 2,914  
    Electronic Access
Departmental 1-5 Users
  USD 4,858  
    Electronic Access
Global Site License Fulfilled By Publisher
  USD 11,688  
US: 800.298.5699
Int'l: +1.240.747.3093

Share this report

    Other tasks

    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!